Andrea Alimonti

17.8k total citations · 6 hit papers
106 papers, 9.1k citations indexed

About

Andrea Alimonti is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Andrea Alimonti has authored 106 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Oncology and 18 papers in Immunology. Recurrent topics in Andrea Alimonti's work include Heavy Metal Exposure and Toxicity (12 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Immune cells in cancer (11 papers). Andrea Alimonti is often cited by papers focused on Heavy Metal Exposure and Toxicity (12 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Immune cells in cancer (11 papers). Andrea Alimonti collaborates with scholars based in Italy, Switzerland and United States. Andrea Alimonti's co-authors include Pier Paolo Pandolfi, Caterina Nardella, Arkaitz Carracedo, Carlos Cordon‐Cardo, Lloyd C. Trotman, Zhenbang Chen, Arianna Calcinotto, John G. Clohessy, Julie Teruya‐Feldstein and Laura Pellegrini and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

Andrea Alimonti

105 papers receiving 8.9k citations

Hit Papers

Inhibition of mTORC1 leads to MAPK pathway activation thr... 2007 2026 2013 2019 2008 2019 2007 2007 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
    2008 1.1k citations Julie Teruya‐Feldstein, Andrea Alimonti et al. profile →
  2. Cellular Senescence: Aging, Cancer, and Injury
    2019 877 citations Andrea Alimonti et al. profile →
  3. Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression
    2007 593 citations Andrea Alimonti, Julie Teruya‐Feldstein et al. profile →
  4. NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
    2007 576 citations Andrea Alimonti, Carlos Cordon‐Cardo et al. profile →
  5. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
    2009 490 citations Andrea Alimonti, Caterina Nardella et al. profile →
  6. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
    2020 343 citations Carlo V. Catapano, Andrea Cavalli et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Alimonti Italy 36 5.2k 2.0k 1.4k 1.3k 1.3k 106 9.1k
Rajiv Kumar Germany 52 5.3k 1.0× 3.2k 1.5× 2.1k 1.5× 650 0.5× 1.3k 1.0× 259 9.6k
Markus Hengstschläger Austria 48 4.5k 0.9× 2.0k 1.0× 1.0k 0.7× 579 0.4× 963 0.8× 216 9.2k
John Lunec United Kingdom 53 5.9k 1.1× 2.7k 1.3× 2.1k 1.5× 859 0.7× 838 0.7× 280 12.3k
Gaetano Cairo Italy 52 3.8k 0.7× 1.8k 0.9× 1.0k 0.7× 1.0k 0.8× 750 0.6× 140 10.8k
Xiaoli Liu China 54 5.8k 1.1× 1.3k 0.7× 1.7k 1.2× 1.5k 1.2× 991 0.8× 525 11.9k
Chiara Riganti Italy 53 4.4k 0.8× 2.2k 1.1× 2.0k 1.4× 1.0k 0.8× 674 0.5× 259 9.2k
Fuquan Yang China 43 4.7k 0.9× 1.0k 0.5× 1.4k 1.0× 1.2k 0.9× 607 0.5× 173 7.9k
Hong Sun United States 46 7.5k 1.5× 1.5k 0.7× 1.3k 1.0× 415 0.3× 532 0.4× 125 10.0k
Steven A. Belinsky United States 57 9.2k 1.8× 2.3k 1.1× 3.1k 2.2× 2.5k 1.9× 654 0.5× 227 12.8k
Frederick E. Domann United States 53 5.0k 1.0× 1.1k 0.5× 1.6k 1.1× 661 0.5× 622 0.5× 162 7.8k

Countries citing papers authored by Andrea Alimonti

Since Specialization
Citations

This map shows the geographic impact of Andrea Alimonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Alimonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Alimonti more than expected).

Fields of papers citing papers by Andrea Alimonti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Alimonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Alimonti. The network helps show where Andrea Alimonti may publish in the future.

Co-authorship network of co-authors of Andrea Alimonti

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Alimonti. A scholar is included among the top collaborators of Andrea Alimonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Alimonti. Andrea Alimonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burrello, Jacopo, Alessio Burrello, Elena Vacchi, et al.. (2024). Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index. PubMed. 10(1). 63–63. 1 indexed citations
2.
Troiani, Martina, Manuel Colucci, Mariantonietta D’Ambrosio, et al.. (2022). Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer. Nature Communications. 13(1). 2177–2177. 71 indexed citations
3.
Bono, Johann S. de, Christina Guo, Bora Gürel, et al.. (2020). Prostate carcinogenesis: inflammatory storms. Nature reviews. Cancer. 20(8). 455–469. 137 indexed citations
4.
Sgrignani, Jacopo, Jingjing Chen, Andrea Alimonti, & Andrea Cavalli. (2018). How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study. Scientific Reports. 8(1). 14683–14683. 16 indexed citations
5.
Chen, Jingjing, Ilaria Guccini, Diletta Di Mitri, Daniela Brina, & Andrea Alimonti. (2017). Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Annals of Oncology. 28. v589–v589. 16 indexed citations
6.
Alimonti, Andrea. (2016). ecancermedicalscience. ecancermedicalscience. 4. 192–192. 7 indexed citations
7.
Alajati, Abdullah, Ilaria Guccini, Sandra Pinton, et al.. (2015). Interaction of CDCP1 with HER2 Enhances HER2-Driven Tumorigenesis and Promotes Trastuzumab Resistance in Breast Cancer. Cell Reports. 11(4). 564–576. 50 indexed citations
8.
Mitri, Diletta Di & Andrea Alimonti. (2015). Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer. Trends in Cell Biology. 26(3). 215–226. 72 indexed citations
9.
Viktorsson, Kristina, Petra Hååg, Katarina Färnegårdh, et al.. (2014). Marine Sponge Cribrochalina vasculum Compounds Activate Intrinsic Apoptotic Signaling and Inhibit Growth Factor Signaling Cascades in Non–Small Cell Lung Carcinoma. Molecular Cancer Therapeutics. 13(12). 2941–2954. 11 indexed citations
10.
Mitri, Diletta Di, Alberto Toso, Jingjing Chen, et al.. (2014). Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature. 515(7525). 134–137. 289 indexed citations
11.
Toso, Alberto, Ajinkya Revandkar, Diletta Di Mitri, et al.. (2014). Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity. Cell Reports. 9(1). 75–89. 322 indexed citations
12.
Leal, Miguel C., Ricardo Calado, Christopher Sheridan, Andrea Alimonti, & Ronald Osinga. (2013). Coral aquaculture to support drug discovery. Trends in biotechnology. 31(10). 555–561. 79 indexed citations
13.
Nardella, Caterina, Andrea Lunardi, Giuseppe Fedele, et al.. (2011). Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis. Cancer Research. 71(10). 3669–3675. 17 indexed citations
14.
Alimonti, Andrea, Beatrice Bocca, Daniela Mattei, & Anna Pino. (2010). Biomonitoring of the Italian population to metals: reference values 1990-2009.. 7 indexed citations
15.
Alimonti, Andrea & Daniela Mattei. (2008). Biomarkers For Human Biomonitoring. 30. 5 indexed citations
16.
Iavicoli, Ivo, Beatrice Bocca, Luca Fontana, et al.. (2008). Distribution and Elimination of Palladium in Male Wistar Rats Following 14-Day Oral Exposure in Drinking Water. Journal of Toxicology and Environmental Health. 72(2). 88–93. 9 indexed citations
17.
Bernardi, Rosa, Ilhem Guernah, David Jin, et al.. (2006). PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR. Nature. 442(7104). 779–785. 314 indexed citations
18.
Bocca, Beatrice, Andrea Alimonti, Francesco Petrucci, et al.. (2004). Quantification of trace elements by sector field inductively coupled plasma mass spectrometry in urine, serum, blood and cerebrospinal fluid of patients with Parkinson's disease. Spectrochimica Acta Part B Atomic Spectroscopy. 59(4). 559–566. 106 indexed citations
19.
Caroli, Sergio, Andrea Alimonti, E. Coni, et al.. (1994). The Assessment of Reference Values for Elements in Human Biological Tissues and Fluids: A Systematic Review. Critical Reviews in Analytical Chemistry. 24(5-6). 363–398. 232 indexed citations
20.
Alimonti, Andrea, Sergio Caroli, Loredana Musmeci, Anna Lina Piccioni, & Giovanni Ziemacki. (1988). Determination of heavy metals in samples of urban solid wastes by means of the ICP atomic spectrometry technique. The Science of The Total Environment. 71(3). 495–500. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajiv Kumar Breakdown of academic impact, for papers by Markus Hengstschläger Breakdown of academic impact, for papers by John Lunec Breakdown of academic impact, for papers by Gaetano Cairo Breakdown of academic impact, for papers by Xiaoli Liu Breakdown of academic impact, for papers by Chiara Riganti Breakdown of academic impact, for papers by Fuquan Yang Breakdown of academic impact, for papers by Hong Sun Breakdown of academic impact, for papers by Steven A. Belinsky Breakdown of academic impact, for papers by Frederick E. Domann
Rankless by CCL
2026